Xuejun Jiang
Impact in
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
- Biomaterials 19
- Electrospun Nanofibers in Biomedical Applications 16
-
- Cardiac Fibrosis and Remodeling 10
- Co-authors
- Xian‐Zheng ZhangDequn WuXin YiRen‐Xi ZhuoTao WangXiaoyan LiXiaoding WangHongling Zhu
- Journals
- International Immunopharmacology (3 papers)Journal of Biomedical Nanotechnology (2 papers)International Journal of Molecular Medicine (2 papers)Frontiers in Cardiovascular Medicine (2 papers)International Journal of Cardiology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xuejun Jiang
77 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 128
- Biomaterials 645
- Molecular Medicine 170
- Cardiology and Cardiovascular Medicine 282
- Surgery 489
- Genetics 110
Countries citing papers authored by Xuejun Jiang
This map shows the geographic impact of Xuejun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuejun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuejun Jiang more than expected).
Fields of papers citing papers by Xuejun Jiang
This network shows the impact of papers produced by Xuejun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuejun Jiang. The network helps show where Xuejun Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuejun Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 18 | |
| 9 | 2017 | 37 | |
| 10 | 2017 | 24 | |
| 11 | 2016 | 2 | |
| 12 | 2015 | 20 | |
| 13 | 2014 | 158 | |
| 14 | 2013 | 9 | |
| 15 | 2012 | 6 | |
| 16 | 2011 | 35 | |
| 17 | 2010 | 32 | |
| 18 | 2009 | 74 | |
| 19 | Intelligent Hydrogel in in situ Myocardial Tissue Engineer | 2008 | 1 |
| 20 | 2008 | 140 |
About Xuejun Jiang
Xuejun Jiang is a scholar working on Biomaterials, Cardiology and Cardiovascular Medicine, Surgery, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 79 papers that have together received 2.0k indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (16 papers), Electrospun Nanofibers in Biomedical Applications (16 papers), Cardiac Fibrosis and Remodeling (10 papers), Coronary Interventions and Diagnostics (8 papers), Epigenetics and DNA Methylation (5 papers), Pulmonary Hypertension Research and Treatments (5 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Biomaterials (645 citations), Molecular Medicine (170 citations), Cardiology and Cardiovascular Medicine (282 citations), Surgery (489 citations) and Genetics (110 citations). Xuejun Jiang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xian‐Zheng Zhang, Dequn Wu, Xin Yi, Ren‐Xi Zhuo, Tao Wang, Xiaoyan Li, Xiaoding Wang, Hongling Zhu, Si‐Xue Cheng and Bo Lü. Their work appears in journals such as International Immunopharmacology, Journal of Biomedical Nanotechnology, International Journal of Molecular Medicine, Frontiers in Cardiovascular Medicine and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.